GERALDINE SOAT BROWN, Magistrate Judge.
Plaintiff Anthony Rossi alleges that he has suffered a permanent disability as a result of a January 2010 automobile accident caused by a truck driven by defendant Steven Groft and owned by defendant U.S. Xpress, Inc. (Not. Rem., Ex. D, Compl.) [Dkt 1.] The court has jurisdiction under 28 U.S.C. § 1332, and the parties have consented to the jurisdiction of the magistrate judge under 28 U.S.C. § 636 [dkt 55]. A jury trial is scheduled to begin on July 8, 2013, and the deadline for the parties' draft pretrial order is June 17, 2013. [Dkt 59.] Before the court are defendants' motion in limine no. 2 (Defs.' MIL No. 2) [dkt 104] and defendants' Rule 37(c)(1) Motion to Strike Dr. Dennis J. Gates' Expert Report and Opinions and to Bar Him From Testifying at Trial (Defs.' Mot. Strike) [dkt 122]. For the reasons stated below, the motion in limine is granted and the motion to strike Dr. Gates' report and bar his testimony is denied.
Defendants' motions argue that Rossi has untimely disclosed proof of nerve ablation treatment for his back pain and has untimely disclosed an updated expert report from his retained medical expert Dr. Gates. The timeline of events leading to these motions, which is central to the their resolution, is set forth below.
In their present motions, defendants move to bar "any and all testimony regarding any nerve ablations" (Defs.' MIL No. 2 ¶ 1), to strike Dr. Gates' March 2013 report, and bar Dr. Gates from testifying at trial. (Defs.' Mot. Strike ¶ 23.) Defendants argue that if such evidence is allowed, the defendants be "permitted time to consult, and, if proper, retain the appropriate . . . expert." (Defs.' MIL no. 2 ¶ 16.)
Under Rule 26(a)(1), a party is required to initially disclose "a copy — or a description by category and location — of all documents . . . that the disclosing party has in its possession, custody, or control and may use to support its claims or defenses. Fed. R. Civ. P. 26(a)(1)(A)(ii). A Rule 26(a)(2)(B) retained expert witness like Dr. Gates is required to provide a report that contains, among other things, "a complete statement of all opinions the witness will express and the basis and reasons for them." Fed. R. Civ. P. 26(a)(2)(B)(I).
For disclosures made under Rule 26(a), a party has the duty to "supplement or correct its disclosure . . . in a timely manner if the party learns that in some material respect the disclosure . . . is incomplete or incorrect, and if the additional or corrective information has not otherwise been made known to the other parties during the discovery process or in writing." Fed. R. Civ. P. 26(e)(1). For expert witnesses, supplementation must be done by the time pretrial disclosures are due. Fed. R. Civ. P. 26(e)(2). Pretrial disclosures must be served at least 30 days before trial, or as ordered by the court. Fed. R. Civ. P. 26(a)(3)(B). If a party fails to disclose supplemental information required by Rule 26(e), the party is not allowed to use that information at trial unless the failure to disclose was substantially justified or harmless. Fed. R. Civ. P. 37(c)(1). The following factors guide a court's analysis: (1) the prejudice or surprise to the party against whom the evidence is offered; (2) the ability of the party to cure the prejudice; (3) the likelihood of disruption to the trial; and (4) the bad faith or willfulness involved in not disclosing the evidence at an earlier date. David v. Caterpillar, Inc., 324 F.3d 851, 857 (7th Cir. 2003).
Nerve ablation was first mentioned as a possible option for Rossi in Dr. Jido's July 18, 2012 treatment record. (Defs.' Mot. Strike, Ex. I.) In September, Rossi's counsel informed defendants' counsel that, along more facet injections, Dr. Jido would "burn the nerve ending off" on October 12. (Id., Ex. G.) The information that Rossi had, in fact, undergone nerve ablation, was not, however, provided to defendants until March 28, 2013, after the deposition of Dr. Jido and after defendants' expert disclosure. Although Dr. Jido's record productions to both Rossi's counsel and defendants' counsel were alike in omitting the October 12 treatment record describing the procedure, Rossi himself knew what medical procedures he had endured. The fact that Rossi's counsel inquired about nerve ablations at Dr. Jido's deposition suggests that he, too, knew that Rossi had undergone the procedure.
If defendants had wondered if Rossi had undergone the procedure, a number of things might have thrown them off the scent. First, the medical bill for the October 12 treatment does not expressly mention nerve ablation. More significant, however, is what happened at Dr. Jido's deposition in February 2013. Although Rossi's counsel asked Dr. Jido about nerve ablation in general, Rossi's counsel did not ask Dr. Jido whether he had administered nerve ablation to Rossi. On the contrary, his questioning omitted any reference to a treatment on October 12. He questioned Dr. Jido about a September 4, 2012 facet injection procedure, and then referred to Dr. Jido having "one more visit with Mr. Rossi then on December 18, 2012" (Jido Dep. at 26), giving the impression that the proposed treatment on October 12 either did not take place or was too insignificant to mention. By the time Rossi disclosed Dr. Jido's record of the procedure on March 28 (a week after Rossi's counsel received it), the time for retaining and disclosing experts had passed.
Thus, defendants have not had an opportunity to question Dr. Jido about his administration of nerve ablations to Rossi, so the late disclosure of the fact that Rossi had actually undergone nerve ablation was neither justified nor harmless. Reopening expert disclosures and testimony at this late date would jeopardize the trial schedule. In light of the fact that Rossi's counsel declined to ask Dr. Jido during his video deposition the direct question, "Did you administer nerve ablation to Mr. Rossi?" it appears that the evidence of nerve ablation could not be particularly significant in Rossi's proof of his treatment and damages. That fact is reinforced by the fact that the October 12 procedure was billed as a "facet nerve injection" and the nerve ablation procedure was not separately identified. Thus, considering the standards described above, defendants' motion in limine is granted. Rossi will not be permitted to present any evidence of, refer to, or argue the fact that he underwent nerve ablation.
The motion to strike Dr. Gates' report and to bar him as a witness is a different matter. Dr Gates' March report reflects the fact that Rossi continues to have medical treatment. This is not the situation where a party attempts to amend an expert report under the guise of supplementation. Dr. Gates' March 25 report appears to be a true supplement based on his evaluation of Rossi's continuing treatment. His modified prognosis opinion is based on Rossi's medical treatment that occurred after Dr. Gates' previous report in January 2012, and Dr. Gates' prognosis opinion does not "threaten to belatedly send the case on a wholly different tack." Talbert v. City of Chicago, 236 F.R.D. 415, 424 (N.D. Ill. 2006). Most of Dr. Gates' opinion, including his diagnosis of Rossi's conditions, remains unchanged from his prior reports. Even his one sentence reference to the nerve ablation procedure is simply an observation that it had not helped Rossi. His supplemental report is not untimely as it was disclosed prior to any deadline mandated by deadline Rule 26(e)(2) and Rule 26(a)(3).
Defendants have not shown that Dr. Gates' March report presents a reason to allow them to retain and disclose an additional expert. Defendants' current retained expert Dr. Rosenblatt did not review any records from Dr. Jido, at least as far as his disclosure indicates. Dr. Rosenblatt has a completely different view of Rossi's medical situation from Dr. Gates' and Dr. Jido's view. Dr. Rosenblatt is of the opinion that Rossi does not have facet joint syndrome in the cervical spine and that Rossi had a cervical strain that normally has a 6 to 12 week recovery period. Given that defendants' expert does not believe that Rossi has cervical facet joint syndrome and does not express any opinion as to Dr. Jido's facet joint injections, it is hard to see why defendants would need another expert to opine on any additional treatment for Rossi's cervical facet joint issues.
Defendants also argue that they have not had a chance to cross-examine Dr. Gates regarding his supplemental opinion. Because Dr. Gates' March Report was disclosed after his deposition, if Rossi wants to introduce any of Dr. Gates's updated opinions, Dr. Gates will have to testify to those opinions at trial where defendants will have an opportunity to cross-examine Dr. Gates, and defendants' witness Dr. Rosenblatt will be able to respond. In light of the ruling above, however, Dr. Gates will not be permitted to mention Rossi's nerve ablation procedure.
For the foregoing reasons, defendants' motion in limine no. 2 [dkt 104] is granted, and defendants' motion to strike Dr. Gates' report and bar him from testifying at trial [dkt 122] is denied.